Key opinion leaders share their impressions of the IMBrave150 trial data and discuss their real-world clinical experiences using atezolizumab plus bevacizumab in practice.
Video content above is prompted by the following:
Stay up to date on recent advances in the multidisciplinary approach to cancer.